Pancreatic Adenocarcinoma, Version 1.2019.

Margaret A. Tempero,Mokenge P. Malafa,E. Gabriela Chiorean,Brian G. Czito,Courtney L. Scaife,Amol K. Narang,Christos Fountzilas,Brian M. Wolpin,Mahmoud M. Al-Hawary,Horacio J. Asbun,Stephen W. Behrman,Al B. Benson,Ellen F. Binder,Dana Backlund Cardin,Charles Cha,Vincent Chung,Mary Dillhoff,Efrat Dotan,Cristina R. Ferrone,George A. Fisher,Jeffrey M. Hardacre,William G. Hawkins,Andrew H. Ko,Noelle K. LoConte,Andrew M. Lowy,Cassadie Moravek,Eric K. Nakakura,Eileen M. O’Reilly,Jorge Obando,Sushanth Reddy,Sarah P. Thayer,Robert A. Wolff,Jennifer L. Burns,Griselda Zuccarino-Catania

Pancreatic Adenocarcinoma, Version 1.2019.

2019

: The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCN Guidelines Insights discuss important updates to the 2019 version of the guidelines, focusing on postoperative adjuvant treatment of patients with pancreatic cancers.

Keywords:

Pathology
Adenocarcinoma
Gastroenterology
Medicine
Internal medicine
Oncology
Exocrine pancreas
General surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations